David E. Joranson

2.9k total citations
57 papers, 2.0k citations indexed

About

David E. Joranson is a scholar working on Public Health, Environmental and Occupational Health, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, David E. Joranson has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Public Health, Environmental and Occupational Health, 41 papers in Anesthesiology and Pain Medicine and 21 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in David E. Joranson's work include Pain Management and Opioid Use (41 papers), Opioid Use Disorder Treatment (32 papers) and Palliative Care and End-of-Life Issues (27 papers). David E. Joranson is often cited by papers focused on Pain Management and Opioid Use (41 papers), Opioid Use Disorder Treatment (32 papers) and Palliative Care and End-of-Life Issues (27 papers). David E. Joranson collaborates with scholars based in United States, India and Pakistan. David E. Joranson's co-authors include Aaron M. Gilson, Karen M. Ryan, June L. Dahl, M. R. Rajagopal, Martha A. Maurer, Seddon R. Savage, Edward C. Covington, Sidney H. Schnoll, Howard A. Heit and J. David Haddox and has published in prestigious journals such as The Lancet, JAMA and Pain.

In The Last Decade

David E. Joranson

55 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Joranson United States 25 1.4k 1.2k 692 332 250 57 2.0k
Aaron M. Gilson United States 24 1.3k 0.9× 976 0.8× 568 0.8× 359 1.1× 168 0.7× 90 1.9k
Gilbert J. Fanciullo United States 22 1.1k 0.8× 1.1k 0.9× 466 0.7× 770 2.3× 347 1.4× 59 2.3k
Jennifer Brennan Braden United States 19 2.1k 1.5× 1.3k 1.1× 614 0.9× 812 2.4× 283 1.1× 25 2.8k
Andrew Kolodny United States 14 1.1k 0.8× 496 0.4× 385 0.6× 321 1.0× 157 0.6× 34 1.7k
Olav Magnus S. Fredheim Norway 18 701 0.5× 672 0.5× 302 0.4× 335 1.0× 163 0.7× 75 1.3k
Jan L. Losby United States 14 1.7k 1.2× 885 0.7× 461 0.7× 398 1.2× 85 0.3× 35 2.1k
Felicita David United States 7 1.3k 1.0× 512 0.4× 418 0.6× 184 0.6× 112 0.4× 10 2.0k
Mark W. Parrino United States 9 1.3k 0.9× 521 0.4× 392 0.6× 196 0.6× 106 0.4× 19 1.6k
Briony Larance Australia 29 2.1k 1.5× 916 0.7× 518 0.7× 656 2.0× 164 0.7× 125 2.8k
Joanna L. Starrels United States 26 1.2k 0.9× 580 0.5× 466 0.7× 446 1.3× 109 0.4× 76 2.2k

Countries citing papers authored by David E. Joranson

Since Specialization
Citations

This map shows the geographic impact of David E. Joranson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Joranson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Joranson more than expected).

Fields of papers citing papers by David E. Joranson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Joranson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Joranson. The network helps show where David E. Joranson may publish in the future.

Co-authorship network of co-authors of David E. Joranson

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Joranson. A scholar is included among the top collaborators of David E. Joranson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Joranson. David E. Joranson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krakauer, Eric L., et al.. (2014). Toward Safe Accessibility of Opioid Pain Medicines in Vietnam and Other Developing Countries: A Balanced Policy Method. Journal of Pain and Symptom Management. 49(5). 916–922. 29 indexed citations
2.
Gilson, Aaron M. & David E. Joranson. (2008). Is the DEA's New “Prescription Series” Regulation Balanced?. Journal of Pain & Palliative Care Pharmacotherapy. 22(3). 218–220. 1 indexed citations
3.
Gallagher, Rollin M., et al.. (2008). Physicians Charged with Opioid Analgesic-Prescribing Offenses. Pain Medicine. 9(6). 737–747. 35 indexed citations
4.
Joranson, David E. & Aaron M. Gilson. (2007). A Much-Needed Window on Opioid Diversion. Pain Medicine. 8(2). 128–129. 7 indexed citations
5.
Gilson, Aaron M., Martha A. Maurer, & David E. Joranson. (2007). State Medical Board Members’ Beliefs About Pain, Addiction, and Diversion and Abuse: A Changing Regulatory Environment. Journal of Pain. 8(9). 682–691. 35 indexed citations
6.
Moşoiu, Daniela, et al.. (2006). Reform of drug control policy for palliative care in Romania. The Lancet. 367(9528). 2110–2117. 25 indexed citations
7.
Gilson, Aaron M., Karen M. Ryan, David E. Joranson, & June L. Dahl. (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of Pain and Symptom Management. 28(2). 176–188. 272 indexed citations
8.
Joranson, David E., et al.. (2003). Italy reforms national policy for cancer pain relief and opioids. European Journal of Cancer Care. 12(1). 28–34. 24 indexed citations
9.
Joranson, David E.. (2003). Pain and the Pharmacist: Opinion #1. Pain Medicine. 4(2). 190–191. 1 indexed citations
10.
Savage, Seddon R., David E. Joranson, Edward C. Covington, et al.. (2003). Definitions related to the medical use of opioids: Evolution towards universal agreement. Journal of Pain and Symptom Management. 26(1). 655–667. 163 indexed citations
11.
Gilson, Aaron M., David E. Joranson, & Martha A. Maurer. (2003). Improving State Medical Board Policies: Influence of a Model. The Journal of Law Medicine & Ethics. 31(1). 119–129. 16 indexed citations
12.
Joranson, David E., Aaron M. Gilson, June L. Dahl, & J. David Haddox. (2002). Pain Management, Controlled Substances, and State Medical Board Policy. Journal of Pain and Symptom Management. 23(2). 138–147. 82 indexed citations
13.
Dahl, June L., et al.. (2002). Success of the State Pain Initiatives. Cancer Practice. 10(s1). S9–S13. 10 indexed citations
14.
Joranson, David E., et al.. (2002). Pain Management and Prescription Monitoring. Journal of Pain and Symptom Management. 23(3). 231–238. 44 indexed citations
15.
Gilson, Aaron M. & David E. Joranson. (2001). Controlled Substances and Pain Management. Journal of Pain and Symptom Management. 21(3). 227–237. 52 indexed citations
16.
Joranson, David E. & Aaron M. Gilson. (1998). Regulatory barriers to pain management. Seminars in Oncology Nursing. 14(2). 158–163. 35 indexed citations
17.
Lima, Liliana De, et al.. (1997). Opioid availability in Latin America: the santo domingo report progress since the Declaration of Florianopolis. Journal of Pain and Symptom Management. 13(4). 213–219. 31 indexed citations
18.
Stjernswärd, Jan, Éduardo Bruera, David E. Joranson, et al.. (1995). Opioid availability in latin america: The declaration of florianopolis. Journal of Pain and Symptom Management. 10(3). 233–236. 28 indexed citations
19.
Joranson, David E.. (1994). Are health-care reimbursement policies a barrier to acute and cancer pain management?. Journal of Pain and Symptom Management. 9(4). 244–253. 29 indexed citations
20.
Joranson, David E.. (1993). Guiding Principles of International and Federal Laws Pertaining to Medical Use and Diversion of Controlled Substances. PsycEXTRA Dataset. 131. 18–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron M. Gilson Breakdown of academic impact, for papers by Gilbert J. Fanciullo Breakdown of academic impact, for papers by Jennifer Brennan Braden Breakdown of academic impact, for papers by Andrew Kolodny Breakdown of academic impact, for papers by Olav Magnus S. Fredheim Breakdown of academic impact, for papers by Jan L. Losby Breakdown of academic impact, for papers by Felicita David Breakdown of academic impact, for papers by Mark W. Parrino Breakdown of academic impact, for papers by Briony Larance Breakdown of academic impact, for papers by Joanna L. Starrels
Rankless by CCL
2026